ZA992079B - Methods and compositions for diagnosis of rheumatoid arthritis. - Google Patents

Methods and compositions for diagnosis of rheumatoid arthritis.

Info

Publication number
ZA992079B
ZA992079B ZA9902079A ZA992079A ZA992079B ZA 992079 B ZA992079 B ZA 992079B ZA 9902079 A ZA9902079 A ZA 9902079A ZA 992079 A ZA992079 A ZA 992079A ZA 992079 B ZA992079 B ZA 992079B
Authority
ZA
South Africa
Prior art keywords
diagnosis
compositions
methods
rheumatoid arthritis
rheumatoid
Prior art date
Application number
ZA9902079A
Inventor
Rajesh Bhikhu Parekh
Robert Reid Townsend
Thakorbhai Parshotambhai Patel
Original Assignee
Oxford Glycosciences Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences Uk Ltd filed Critical Oxford Glycosciences Uk Ltd
Publication of ZA992079B publication Critical patent/ZA992079B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9902079A 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis. ZA992079B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9805477.8A GB9805477D0 (en) 1998-03-13 1998-03-13 Methods and compositions for diagnosis of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
ZA992079B true ZA992079B (en) 2000-10-10

Family

ID=10828567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902079A ZA992079B (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis.

Country Status (8)

Country Link
EP (1) EP1062509A2 (en)
JP (1) JP2002507723A (en)
CN (1) CN1300367A (en)
AU (1) AU756588B2 (en)
CA (1) CA2323238A1 (en)
GB (1) GB9805477D0 (en)
WO (1) WO1999047925A2 (en)
ZA (1) ZA992079B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) * 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
ATE406627T1 (en) 2000-06-19 2008-09-15 Correlogic Systems Inc HEURISTIC CLASSIFICATION METHOD
CA2415775A1 (en) 2000-07-18 2002-01-24 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
WO2002054079A2 (en) * 2000-10-24 2002-07-11 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of cardiac response
EP1405072A2 (en) * 2000-12-29 2004-04-07 Oxford GlycoSciences (UK) Limited Proteins, genes and their use for diagnosis and treatment of kidney response
EP1368647A2 (en) * 2000-12-29 2003-12-10 Oxford GlycoSciences (UK) Limited Proteins, genes and their use for diagnosis and treatment of vascular response
DE10127572A1 (en) * 2001-05-30 2002-12-05 Pathoarray Gmbh Tools for the diagnosis, molecular definition and therapy development of chronic inflammatory joint diseases
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US7333895B2 (en) 2002-07-29 2008-02-19 Correlogic Systems, Inc. Quality assurance for high-throughput bioassay methods
JP2007504463A (en) * 2003-09-05 2007-03-01 ロイヤル ウィメンズ ホスピタル Diagnostic markers for ovarian cancer
US7761239B2 (en) 2003-12-11 2010-07-20 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
CN101855553B (en) 2007-06-29 2014-06-11 韩国安国药品株式会社 Predictive markers for ovarian cancer
ES2568702B1 (en) * 2014-10-01 2017-02-13 Servizo Galego De Saude (Sergas) METHOD FOR THE DIAGNOSIS OF ARTROSIS
CN106950365B (en) * 2017-02-15 2018-11-27 中国医学科学院北京协和医院 A kind of RA diagnosis marker of ACPA feminine gender and its application
CN108732253A (en) * 2017-04-14 2018-11-02 杭州量康科技有限公司 Peptide fragment composition and assay method for serous proteinquatative measurement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580882D1 (en) * 1984-09-14 1991-01-24 Asahi Medical Co A PROTEIN SPECIFICALLY PURE FOR RHEUMATOID ARTHRITIS AND AN ANTIBODY AGAINST IT.
EP0378732A1 (en) * 1989-01-20 1990-07-25 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Serum proteins related to autoimmune disease
US5837686A (en) * 1991-11-25 1998-11-17 Peptide Therapeutics Limited Peptides and antibodies for treatment of rheumatoid arthritis
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
AU756588B2 (en) 2003-01-16
JP2002507723A (en) 2002-03-12
CA2323238A1 (en) 1999-09-23
AU2942999A (en) 1999-10-11
WO1999047925A2 (en) 1999-09-23
WO1999047925A3 (en) 1999-11-25
GB9805477D0 (en) 1998-05-13
EP1062509A2 (en) 2000-12-27
CN1300367A (en) 2001-06-20

Similar Documents

Publication Publication Date Title
AU2002230997A1 (en) Methods and compositions for diagnosing and treating rheumatoid arthritis
SG81321A1 (en) Pierceable stopper and method of producing the same
ZA992079B (en) Methods and compositions for diagnosis of rheumatoid arthritis.
EP1275398A4 (en) Diagnostics and remedies for rheumatoid arthritis
ZA991953B (en) Detection of fermentation-related microorganisms.
BG105437A (en) Rheoogy modified compositions and processes thereof
EP1255765A4 (en) Pharmaceutical compositions and methods for treating rheumatoid arthritis
HK1037918A1 (en) olymorph of ritonavir.
EP1056457A4 (en) S-lansoprazole compositions and methods
AU4577999A (en) Methods and compositions for inhibiting corrosion
EP1073333A4 (en) S-rabeprazole compositions and methods
ZA989036B (en) Methods and compositions for treating rheumatoid arthritis.
EP1139981A4 (en) Compositions and methods of using the same
ZA982338B (en) Method for the diagnosis of rheumatoid arthritis
IL137439A0 (en) Method for the determination of prosthetic infections
AU2433100A (en) Methods and compositions for the fixation of trace amounts of radiocaesium
PL344785A1 (en) Methods for increasing levels of acetylcholine
IL138914A0 (en) Methods for increasing levels of acetylcholine
ZA99835B (en) Preparation of microballoons.
EP1073332A4 (en) R-rabeprazole compositions and methods
HUP0100613A3 (en) Methods and compositions for stabilizing acetylcholine compositions
SI1021200T1 (en) Methods and compositions for treating rheumatoid arthritis
ZA991295B (en) Construction form compositions and process for making construction forms.
ZA991184B (en) Methods and compositions for diagnosis of hepatoma.
GB2333109B (en) Foundations and method of forming the same